Pediatrix Medical Group, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Vanguard Portfolio Management has filed a Schedule 13G amendment to correct a previously reported CIK number for Pediatrix Medical Group, Inc., confirming no change in beneficial ownership.
NYSE
Vanguard Capital Management has filed a Schedule 13G amendment to correct a previously reported CIK number for Pediatrix Medical Group, Inc., confirming no change in beneficial ownership.
NYSE
SCHEDULE: Vanguard Discloses Zero Pediatrix Shares
The Vanguard Group has filed an amendment to its Schedule 13G, reporting zero shares beneficially owned in Pediatrix Medical Group, Inc., and correcting a prior CIK error.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a beneficial ownership of 14.6% in Pediatrix Medical Group, Inc.'s common stock.
NYSE
AllianceBernstein L.P. has filed an Amendment No. 6 to Schedule 13G, disclosing a 2.2% beneficial ownership stake in Pediatrix Medical Group Inc. as of May 31, 2025.
NYSE
AllianceBernstein L.P. has filed an amended Schedule 13G, reporting an 8.0% passive ownership stake in Pediatrix Medical Group Inc. as of March 31, 2025.
NYSE
Rubric Capital Management LP and David Rosen have reported a 3.67% beneficial ownership stake in Pediatrix Medical Group, Inc. as of December 31, 2024, held for investment purposes.